Holen Sie sich die Stockscreener-App
203.50
0.40%
-0.81
Handel nachbörslich:
203.50
Insulet Corporation Aktie (PODD) Neueste Nachrichten
Robust 2025 growth, new leadership in Insulet (NASDAQ: PODD) 2026 proxy - Stock Titan
Insulet announces recall of Omnipod 5 Pods due to insulin delivery issue - Class Action Lawsuits
Insulet Corp. Stock Plummets to New 52-Week Low of $203.19 - Markets Mojo
Insulet Corporation (PODD) Stock forecasts - Yahoo Finance UK
Aberdeen Group plc Has $64.08 Million Stock Position in Insulet Corporation $PODD - MarketBeat
PODD PE Ratio & Valuation, Is PODD Overvalued - Intellectia AI
Insulet (PODD): 3 Reasons We Love This Stock - Yahoo Finance
Insulet (PODD) is a Top-Ranked Growth Stock: Should You Buy? - Yahoo Finance
Insulet Corp. Stock Hits 52-Week Low at USD 208.14 - Markets Mojo
Assessing Insulet (PODD) Valuation After Omnipod 5 Device Correction And Maintained Outlook - Sahm
Insulet Corp. stock outperforms competitors despite losses on the day - MarketWatch
Insulet Corp (PODD) EVP receives new stock options and RSU awards - Stock Titan
INSULET CORP (PODD) EVP and CCO Michael Panos reports 5-share stake - Stock Titan
Insulet (PODD) board member elects 111 deferred stock units as fees - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet CorporationPODD - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Insulet Corporation (PODD) And Encourages Shareholders to Connect - ACCESS Newswire
Insulet Corp (NASDAQ:PODD): A Prime GARP Investment with Strong Growth and Reasonable Valuation - ChartMill
Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026 - BioSpace
PODD Stock Price, Quote & Chart | INSULET CORP (NASDAQ:PODD) - ChartMill
Diabetes Focused MiniMed Recovery Story Builds As Pipeline Improves - Sahm
Insulet Corp (1PODD.MI) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Insulet Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Insulet Corporation (PODD) Stock Forecasts - Yahoo Finance
Insulet Corporation Trade Ideas — MIL:1PODD - TradingView
PODD Investor Alert: Insulet Corp. Potential Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Device Defect: Levi & Korsinsky - Morningstar
Does Insulet (PODD) Elevate Its Diabetes Tech Edge With Panos Steering Global Commercial Strategy? - Yahoo Finance
7,473 Shares in Insulet Corporation $PODD Acquired by J. Safra Sarasin Holding AG - marketbeat.com
Truist maintains Insulet Corporation (PODD) buy rating despite device correction announcement - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Insulet Corporation (PODD) And Encourages Shareholders to Reach Out - ACCESS Newswire
Why (PODD) Price Action Is Critical for Tactical Trading - Stock Traders Daily
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet ... - Bluefield Daily Telegraph
Winners And Losers Of Q4: Insulet (NASDAQ:PODD) Vs The Rest Of The Patient Monitoring Stocks - Yahoo Finance
Zevenbergen Capital Investments LLC Invests $32.14 Million in Insulet Corporation $PODD - MarketBeat
Insulet (NASDAQ:PODD) Reaches New 12-Month LowTime to Sell? - marketbeat.com
Insulet names Mike Panos as chief commercial officer By Investing.com - Investing.com South Africa
Insulet Appoints Mike Panos as Chief Commercial Officer - gurufocus.com
Insulet Earnings: Stellar Finish to 2025 With Strong Fourth Quarter - Morningstar
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Insulet Corporation (PODD) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Insulet Corp. Stock Hits New 52-Week Low at USD 215.26 - Markets Mojo
Consumer safety roundup: Major recalls affect Einstein Bros., Insulet, Amneal and Falcon Trading - Washington Times
Insulet Corp (PODD) Shares Down 4.53% on Mar 30 - gurufocus.com
Is Insulet’s (PODD) New CCO Hire a Subtle Reset of Its Global Commercial Strategy? - simplywall.st
Insulet Corporation Appoints Mike Panos as Executive Vice President and Chief Commercial Officer, Effective March 30, 2026 - marketscreener.com
Insulet names Mike Panos as chief commercial officer - Investing.com
Truist Maintains Insulet Corporation (PODD) Buy Rating Despite Device Correction Announcement - Insider Monkey
SG Americas Securities LLC Purchases 36,570 Shares of Insulet Corporation $PODD - MarketBeat
Beacon Investment Advisory Services Inc. Cuts Position in Insulet Corporation $PODD - MarketBeat
Insulet Corporation (PODD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Insulet recalling certain defective Omnipod insulin delivery devices - MSN
PODD Investors Have Opportunity to Join Insulet Corporation Fraud Investigation with the Schall Law Firm - Business Wire
Is Insulet stock underperforming the Dow? - MSN
Insulet Corp. stock underperforms Friday when compared to competitors - MarketWatch
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):